Long-term opioid use does not improve chronic back pain outcomes
Taking opioids for years does not seem to improve pain and functioning in people with chronic back pain,…
The heart effects of antidepressants may depend as much on the patient as the drug
A major analysis of randomized trials tracked changes in heart rhythm across 10 antidepressants and examined how age,…
Add-on drug lumateperone boosts sexual function in patients with depression
Patients with major depressive disorder (MDD) and an inadequate response to standard antidepressants who received an add- on…
GLP-1 drugs appear psychiatrically safe, but one finding still raises questions
With millions of patients now taking GLP-1 drugs, researchers examined whether concerns about depression and suicidality are supported…
Doctor says extreme heat can affect people on GLP-1 medications
Doctor says extreme heat can affect people on GLP-1 medications Heat, dehydration and certain medications can be a…
Cannabidiol shows preclinical promise for anxiety, depression and cognition
A new Molecular Psychiatry meta-analysis suggests CBD may improve emotional behavior and cognition in animal models, but researchers…
Popular antidepressant recalled for high levels of a potentially cancer-causing chemical
(Gray News) — A popular antidepressant is being recalled for high levels of a potentially cancer-causing chemical. The…
Popular antidepressant recalled for high levels of a potentially cancer-causing chemical
(Gray News) — A popular antidepressant is being recalled for high levels of a potentially cancer-causing chemical. The…
Popular antidepressant recalled for high levels of a potentially cancer-causing chemical
(Gray News) — A popular antidepressant is being recalled for high levels of a potentially cancer-causing chemical. The…
Popular antidepressant recalled for high levels of a potentially cancer-causing chemical
(Gray News) — A popular antidepressant is being recalled for high levels of a potentially cancer-causing chemical. The…
Anti-inflammatory drug tocilizumab shows promise for difficult-to-treat depression
Immunotherapy could be a promising new treatment option for patients with difficult-to-treat depression. This is a key finding from a University…
NOX-1 identified as key molecular target to prolong ketamine’s antidepressant effects
Treatment-resistant depression affects a large proportion of people with major depressive disorder, and while ketamine offers rapid relief,…